The European Commission (EC) has published a new version of the Questions and Answers document “Safety Features for Medicinal Products for Human Use (V.22)”.
The document is available on the websites of the European Medicines Verification Organisation (EMVO), the European Commission, and the Latvian Medicines verification organisation, under the “Documents” section.
Changes have been made to sections 1.22, 2.3, 2.12, 2.21, 2.22 and 8.9, and a new question and answer, 7.21, has been added.
The modifications from the previous version have been highlighted for your convenience.
If you have any questions, please contact EMVO at [email protected].